Natural protease inhibitors to fibrinolysis in liver diseases.
The newly discovered alpha 2-antiplasmin and some inhibitors of fibrinolysis were measured in 40 patients with liver diseases. alpha 2-antiplasmin was low in liver cirrhosis, but unchanged in cholestasis when compared with controls.
D000328:Adult; D000368:Aged; D000990:Antithrombin III / Q000032:analysis; D005260:Female; D005342:Fibrinolysis; D006801:Humans; D008107:Liver Diseases / Q000097:blood* / Q000201:enzymology; D008297:Male; D008875:Middle Aged; D011480:Protease Inhibitors / Q000097:blood*; D014568:Urokinase-Type Plasminogen Activator / Q000037:antagonists & inhibitors; D000979:alpha-2-Antiplasmin / Q000032:analysis; D000511:alpha-Macroglobulins / Q000032:analysis
D011480:Protease Inhibitors; D000979:alpha-2-Antiplasmin; D000511:alpha-Macroglobulins; D000990:Antithrombin III; D014568:Urokinase-Type Plasminogen Activator